209 related articles for article (PubMed ID: 26385505)
1. Glycosylated hemoglobin is associated with decreased endothelial function, high inflammatory response, and adverse clinical outcome in non-diabetic STEMI patients.
Moura FA; Figueiredo VN; Teles BS; Barbosa MA; Pereira LR; Costa AP; Carvalho LS; Cintra RM; Almeida OL; Quinaglia E Silva JC; Nadruz Junior W; Sposito AC;
Atherosclerosis; 2015 Nov; 243(1):124-30. PubMed ID: 26385505
[TBL] [Abstract][Full Text] [Related]
2. Clinical influence of early follow-up glycosylated hemoglobin levels on cardiovascular outcomes in diabetic patients with ST-segment elevation myocardial infarction after coronary reperfusion.
Ahn J; Hong TJ; Park JS; Lee HW; Oh JH; Choi JH; Lee HC; Cha KS; Yun E; Jeong MH; Chae SC; Kim YJ; Hur SH; Seong IW; Jang YS; Cho MC; Kim CJ; Seung KB; Rha SW; Bae JH; Park SJ;
Coron Artery Dis; 2015 Nov; 26(7):555-61. PubMed ID: 25933028
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic value of HbA1c and plasma glucose on one-year mortality in non-diabetic patients after myocardial infarction].
Gueniat-Ratheau E; Yao H; Debeaumarche H; Maalem B; Lairet C; Maza M; Bichat F; Zeller M; N'Guetta R; Cottin Y
Ann Cardiol Angeiol (Paris); 2020 Oct; 69(4):180-191. PubMed ID: 32854906
[TBL] [Abstract][Full Text] [Related]
4. Hemoglobin A1c and short-term outcomes in patients with acute myocardial infarction undergoing primary angioplasty: an observational multicenter study.
Tian L; Zhu J; Liu L; Liang Y; Li J; Yang Y
Coron Artery Dis; 2013 Jan; 24(1):16-22. PubMed ID: 23168569
[TBL] [Abstract][Full Text] [Related]
5. Impact of initial glycosylated hemoglobin level on cardiovascular outcomes in prediabetic patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Shin D; Ahn J; Cha KS; Park JS; Oh JH; Lee HW; Hong JY; Kim BW; Hong TJ;
Coron Artery Dis; 2016 Jan; 27(1):40-6. PubMed ID: 26398151
[TBL] [Abstract][Full Text] [Related]
6. Association of the longitudinal trajectory of urinary albumin/creatinine ratio in diabetic patients with adverse cardiac event risk: a retrospective cohort study.
Li H; Ren Y; Duan Y; Li P; Bian Y
Front Endocrinol (Lausanne); 2024; 15():1355149. PubMed ID: 38745945
[TBL] [Abstract][Full Text] [Related]
7. Optimal glucose, HbA1c, glucose-HbA1c ratio and stress-hyperglycaemia ratio cut-off values for predicting 1-year mortality in diabetic and non-diabetic acute myocardial infarction patients.
Sia CH; Chan MH; Zheng H; Ko J; Ho AF; Chong J; Foo D; Foo LL; Lim PZ; Liew BW; Chai P; Yeo TC; Tan HC; Chua T; Chan MY; Tan JWC; Bulluck H; Hausenloy DJ
Cardiovasc Diabetol; 2021 Oct; 20(1):211. PubMed ID: 34666746
[TBL] [Abstract][Full Text] [Related]
8. Hemoglobin A1c is a better predictor of prognosis following the non-ST elevation acute coronary syndrome than fasting and admission glucose.
Kmet M; Rajer B; Pernat A
Wien Klin Wochenschr; 2014 Mar; 126(5-6):156-62. PubMed ID: 24297265
[TBL] [Abstract][Full Text] [Related]
9. HDL levels and oxidizability during myocardial infarction are associated with reduced endothelial-mediated vasodilation and nitric oxide bioavailability.
Carvalho LS; Panzoldo N; Santos SN; Modolo R; Almeida B; Quinaglia E Silva JC; Nadruz W; de Faria EC; Sposito AC;
Atherosclerosis; 2014 Dec; 237(2):840-6. PubMed ID: 25463131
[TBL] [Abstract][Full Text] [Related]
10. Elevated CETP activity during acute phase of myocardial infarction is independently associated with endothelial dysfunction and adverse clinical outcome.
Carvalho LS; Virginio VW; Panzoldo NB; Figueiredo VN; Santos SN; Modolo RG; Andrade JM; Quinaglia E Silva JC; Nadruz-Junior W; de Faria EC; Sposito AC;
Atherosclerosis; 2014 Dec; 237(2):777-83. PubMed ID: 25463120
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Serum Uric Acid, Bilirubin, and C-Reactive Protein as Prognostic Biomarkers of In-Hospital MACE Between Women and Men With ST-Segment Elevation Myocardial Infarction.
Baumann S; Huseynov A; Koepp J; Jabbour C; Behnes M; Becher T; Renker M; Lang S; Borggrefe M; Lehmann R; Akin I
Angiology; 2016 Mar; 67(3):272-80. PubMed ID: 26032849
[TBL] [Abstract][Full Text] [Related]
12. Impact of glycemic control status on patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
Li Y; Li X; Zhang Y; Zhang L; Wu Q; Bai Z; Si J; Zuo X; Shi N; Li J; Chu X
BMC Cardiovasc Disord; 2020 Jan; 20(1):36. PubMed ID: 32000678
[TBL] [Abstract][Full Text] [Related]
13. Impact of persistent endothelial dysfunction in an infarct-related coronary artery on future major adverse cardiovascular event occurrence in STEMI survivors.
Horikoshi T; Nakamura T; Yoshizaki T; Watanabe Y; Uematsu M; Kobayashi T; Nakamura K; Saito Y; Obata JE; Kugiyama K
Heart Vessels; 2021 Apr; 36(4):472-482. PubMed ID: 33196904
[TBL] [Abstract][Full Text] [Related]
14. Influence of admission glucose profile and hemoglobin A1c on complications of acute myocardial infarction in diabetic patients.
Vujosevic S; Radojevic N; Belada N
Eur Rev Med Pharmacol Sci; 2013 May; 17(9):1252-7. PubMed ID: 23690196
[TBL] [Abstract][Full Text] [Related]
15. Glycated hemoglobin and long-term prognosis in patients with suspected stable angina pectoris without diabetes mellitus: a prospective cohort study.
Rebnord EW; Pedersen ER; Strand E; Svingen GF; Meyer K; Schartum-Hansen H; Løland KH; Seifert R; Ueland PM; Nilsen DW; Nordrehaug JE; Nygård O
Atherosclerosis; 2015 May; 240(1):115-20. PubMed ID: 25770690
[TBL] [Abstract][Full Text] [Related]
16. Glucose dysregulation in nondiabetic patients with ST-elevation myocardial infarction: acute and chronic glucose dysregulation in STEMI.
Rasoul S; Ottervanger JP; Bilo HJ; Timmer JR; van 't Hof AW; Dambrink JH; Dikkeschei LD; Hoorntje JC; de Boer MJ; Zijlstra F
Neth J Med; 2007 Mar; 65(3):95-100. PubMed ID: 17387235
[TBL] [Abstract][Full Text] [Related]
17. Impact of elevated HbA1c on long-term mortality in patients presenting with acute myocardial infarction in daily clinical practice: insights from a 'real world' prospective registry of the Zwolle Myocardial Infarction Study Group.
Hermanides RS; Kennedy MW; Kedhi E; van Dijk PR; Timmer JR; Ottervanger JP; Dambrink JH; Gosselink AM; Roolvink V; Miedema K; Slingerland RJ; Koopmans P; Bilo HJ; van 't Hof AW
Eur Heart J Acute Cardiovasc Care; 2020 Sep; 9(6):616-625. PubMed ID: 31124695
[TBL] [Abstract][Full Text] [Related]
18. Outcomes after primary coronary intervention with drug-eluting stent implantation in diabetic patients with acute ST elevation myocardial infarction.
Zhang Q; Shen J; Zhang RY; Qiu JP; Lu JD; Zhang Y; Chen YH; Zhang JF; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
Chin Med J (Engl); 2007 Nov; 120(21):1862-7. PubMed ID: 18067756
[TBL] [Abstract][Full Text] [Related]
19. Two-year prognosis of admission hemoglobin A1c following a primary percutaneous coronary intervention.
Çiçek G; Korkmaz A
Coron Artery Dis; 2016 Dec; 27(8):673-681. PubMed ID: 27433996
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Hemoglobin A1c Levels in Postmenopausal Diabetic Patients Undergoing Percutaneous Coronary Intervention (PCI) for Acute Coronary Syndrome.
Lao Y; Feng L; Yuan Y; Zhang J; Huang X; Li M; Wu Z
Med Sci Monit; 2018 Dec; 24():9399-9405. PubMed ID: 30587845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
